Skip to main content
AH

AiMorphous Health

AiMorphous Health develops AI-powered blood diagnostic tests that detect early biomarkers of thrombosis and bleeding risk. Their machine learning algorithms analyze blood samples to identify subtle patterns missed by conventional methods, enabling earlier intervention. The technology aims to reduce cardiovascular events and improve patient outcomes.

Roux, SwitzerlandFounded 20222100+ followers
Updated 20 months ago

Funding

$40K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Thrombosis, a major contributor to heart attacks and strokes, often goes undetected in its early stages, leading to preventable deaths. Current diagnostic methods lack the sensitivity to reliably identify individuals at risk of developing thrombosis before it manifests clinically. This absence of early detection tools results in a significant number of preventable thrombosis cases progressing to life-threatening events.

Solution

AiMorphous Health is developing an AI-powered blood diagnostic system designed for the early prediction of thrombosis risk. The system employs advanced machine learning algorithms to analyze blood samples, identifying subtle biomarkers indicative of early-stage thrombosis. By detecting these biomarkers with high accuracy and precision, the technology enables timely intervention and preventative treatment strategies. This proactive approach aims to significantly reduce the incidence of thrombosis-related complications and improve patient outcomes by addressing the condition before it escalates.

Target Audience

The primary target audience includes healthcare providers, hospitals, and diagnostic laboratories seeking advanced tools for early thrombosis risk assessment.

Features

  • AI-driven analysis of blood samples for early detection of thrombosis biomarkers
  • Machine learning models trained to identify subtle patterns indicative of thrombosis risk
  • High sensitivity and specificity in detecting early-stage thrombosis
  • Potential to enable timely intervention and preventative treatment
This profile is AI-generated and may contain inaccuracies.